| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.99e-06 | 5 | 118 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 9.10e-06 | 82 | 118 | 6 | GO:1990756 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.82e-05 | 55 | 118 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 2.12e-05 | 95 | 118 | 6 | GO:0140767 | |
| GeneOntologyMolecularFunction | complement component C3b receptor activity | 3.46e-05 | 2 | 118 | 2 | GO:0004877 | |
| GeneOntologyMolecularFunction | complement component C4b receptor activity | 3.46e-05 | 2 | 118 | 2 | GO:0001861 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MAGEA2 MAGEA3 MAGEA6 PRAMEF7 FLNA MAGEA11 MAGEA12 HIF1A PRAMEF15 TRIM68 PRAMEF4 PRAMEF8 PRAMEF27 | 4.06e-05 | 582 | 118 | 13 | GO:0140297 |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 5.51e-05 | 13 | 118 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | complement component C4b binding | 1.03e-04 | 3 | 118 | 2 | GO:0001855 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.24e-04 | 187 | 118 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 2.41e-04 | 147 | 118 | 6 | GO:0042826 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 3.42e-04 | 5 | 118 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | transcription factor binding | MAGEA2 MAGEA3 MAGEA6 PRAMEF7 FLNA MAGEA11 MAGEA12 HIF1A PRAMEF15 TRIM68 PRAMEF4 PRAMEF8 PRAMEF27 | 5.12e-04 | 753 | 118 | 13 | GO:0008134 |
| GeneOntologyMolecularFunction | complement binding | 8.81e-04 | 32 | 118 | 3 | GO:0001848 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 8.87e-04 | 337 | 118 | 8 | GO:0031625 | |
| GeneOntologyMolecularFunction | opsonin receptor activity | 9.47e-04 | 8 | 118 | 2 | GO:0001847 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 1.31e-03 | 358 | 118 | 8 | GO:0044389 | |
| GeneOntologyMolecularFunction | frizzled binding | 1.95e-03 | 42 | 118 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 2.20e-03 | 12 | 118 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 2.20e-03 | 12 | 118 | 2 | GO:0001851 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | PRAMEF7 HIF1A WNT5A PRAMEF15 PRAMEF4 CUBN PRAMEF8 CR1 CR1L WDR19 JAG2 HOXA11 TBC1D32 HOXC4 HOXD11 FZD5 LPA LRP6 DMBT1 SPIC | 1.30e-07 | 906 | 115 | 20 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | PRAMEF7 HIF1A WNT5A PRAMEF15 PRAMEF4 CUBN PRAMEF8 CR1 CR1L WDR19 JAG2 HOXA11 TBC1D32 HOXC4 HOXD11 FZD5 LPA LRP6 DMBT1 SPIC | 1.94e-07 | 929 | 115 | 20 | GO:0009792 |
| GeneOntologyBiologicalProcess | embryo development | PRAMEF7 LRAT HIF1A ACD WNT5A PRAMEF15 PRAMEF4 CUBN PRAMEF8 CR1 CR1L RYR2 WDR19 JAG2 HOXA11 TBC1D32 HOXC4 HOXD11 FZD5 LPA LRP6 DMBT1 ATP5F1A SPIC | 1.04e-06 | 1437 | 115 | 24 | GO:0009790 |
| GeneOntologyBiologicalProcess | pattern specification process | HIF1A ACD WNT5A APC IRX4 WDR19 HOXA11 TBC1D32 HOXC4 HOXC8 CELSR2 HOXD11 FZD5 LRP6 | 1.39e-06 | 526 | 115 | 14 | GO:0007389 |
| GeneOntologyBiologicalProcess | regionalization | HIF1A ACD WNT5A APC WDR19 HOXA11 TBC1D32 HOXC4 HOXC8 CELSR2 HOXD11 FZD5 LRP6 | 2.69e-06 | 478 | 115 | 13 | GO:0003002 |
| GeneOntologyBiologicalProcess | limb development | 4.64e-06 | 224 | 115 | 9 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 4.64e-06 | 224 | 115 | 9 | GO:0048736 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | PRAMEF7 HIF1A PRAMEF15 PRAMEF4 CUBN PRAMEF8 CR1 CR1L WDR19 JAG2 FZD5 LPA DMBT1 SPIC | 5.92e-06 | 596 | 115 | 14 | GO:0001701 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | FLNA HIF1A PSG3 WNT5A SLC26A4 APC ETV4 IRX4 RYR2 WDR19 JAG2 HOXA11 HOXC4 HOXC8 HOXD11 BTBD7 FZD5 ACAN PITX3 LRP6 EPHB1 | 6.38e-06 | 1269 | 115 | 21 | GO:0009887 |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 1.02e-05 | 247 | 115 | 9 | GO:0009952 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | PRAMEF7 HIF1A PRAMEF9 KREMEN1 PSG3 WNT5A PRAMEF15 APC SEMA5A PRAMEF4 EXTL3 PRAMEF8 CR1 CRHR2 LPA PITX3 LRP6 MMP11 PRAMEF27 EPHB1 | 1.26e-05 | 1220 | 115 | 20 | GO:0051093 |
| GeneOntologyBiologicalProcess | epithelium development | FLNA HIF1A PSG3 WNT5A APC ETV4 SEMA5A EXTL3 CRHR2 RYR2 WDR19 JAG2 HOXA11 TBC1D32 HOXD11 BTBD7 FZD5 PITX3 LRP6 DMBT1 PALLD ADAMTSL2 | 1.79e-05 | 1469 | 115 | 22 | GO:0060429 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 1.95e-05 | 148 | 115 | 7 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 1.95e-05 | 148 | 115 | 7 | GO:0035113 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 3.01e-05 | 107 | 115 | 6 | GO:0009953 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | PRAMEF7 FLNA ICOSLG HIF1A PRAMEF9 RASA1 WNT5A PRAMEF15 SEMA5A PRAMEF4 EXTL3 PRAMEF8 CR1 CD3E EGR3 ACAN PITX3 LRP6 PRAMEF27 | 3.07e-05 | 1190 | 115 | 19 | GO:0008284 |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 3.52e-05 | 110 | 115 | 6 | GO:2000027 | |
| GeneOntologyBiologicalProcess | response to muscle activity | 3.74e-05 | 34 | 115 | 4 | GO:0014850 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 3.74e-05 | 34 | 115 | 4 | GO:0086019 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 4.31e-05 | 114 | 115 | 6 | GO:0033077 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 4.71e-05 | 36 | 115 | 4 | GO:0007274 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 5.39e-05 | 236 | 115 | 8 | GO:0061138 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 5.85e-05 | 74 | 115 | 5 | GO:0042733 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 7.08e-05 | 77 | 115 | 5 | GO:0035567 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 8.08e-05 | 185 | 115 | 7 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 8.08e-05 | 185 | 115 | 7 | GO:0035108 | |
| GeneOntologyBiologicalProcess | brain development | FLNA HIF1A WNT5A SEMA5A CRTAC1 RTN1 CD3E CELSR2 PITX3 SEC16A SLITRK5 LRP6 HSD3B2 VPS13B EPHB1 | 8.59e-05 | 859 | 115 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | tube development | FLNA HIF1A RASA1 PSG3 WNT5A ETV4 SEMA5A CRHR2 RYR2 WDR19 HOXA11 TBC1D32 PTPRB HOXD11 EGR3 FZD5 LPA LRP6 ADAMTSL2 EPHB1 | 8.98e-05 | 1402 | 115 | 20 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of cell proliferation in midbrain | 9.21e-05 | 3 | 115 | 2 | GO:1904933 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway involved in heart development | 9.21e-05 | 3 | 115 | 2 | GO:0061341 | |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte development | 9.21e-05 | 3 | 115 | 2 | GO:1902761 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 1.00e-04 | 258 | 115 | 8 | GO:0001763 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | PRAMEF7 PRAMEF9 PSG3 WNT5A PRAMEF15 SEMA5A PRAMEF4 EXTL3 PRAMEF8 CR1 PITX3 LRP6 MMP11 PRAMEF27 EPHB1 | 1.05e-04 | 875 | 115 | 15 | GO:0045596 |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 1.15e-04 | 45 | 115 | 4 | GO:0031076 | |
| GeneOntologyBiologicalProcess | circulatory system development | FLNA HIF1A RASA1 PSG3 WNT5A APC SEMA5A CRHR2 IRX4 RYR2 TBC1D32 PTPRB EGR3 FZD5 ACAN LPA SLITRK5 LRP6 CACNA1G EPHB1 | 1.32e-04 | 1442 | 115 | 20 | GO:0072359 |
| GeneOntologyBiologicalProcess | camera-type eye development | 1.38e-04 | 426 | 115 | 10 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | HIF1A PSG3 WNT5A APC ETV4 SEMA5A EXTL3 PTPRK EGR3 LRP6 ATP5F1A | 1.43e-04 | 514 | 115 | 11 | GO:0050678 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.56e-04 | 351 | 115 | 9 | GO:0048562 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | PRAMEF7 FLNA SPATA6 WNT5A PRAMEF15 APC PRAMEF4 PRAMEF8 WDR19 RIMBP3 JAG2 HOXA11 FZD5 LPA LRP6 RIMBP3C RIMBP3B VPS13B | 1.62e-04 | 1235 | 115 | 18 | GO:0003006 |
| GeneOntologyBiologicalProcess | tube morphogenesis | FLNA HIF1A RASA1 PSG3 WNT5A ETV4 SEMA5A CRHR2 RYR2 HOXA11 PTPRB HOXD11 EGR3 FZD5 LPA LRP6 EPHB1 | 1.64e-04 | 1125 | 115 | 17 | GO:0035239 |
| GeneOntologyBiologicalProcess | skeletal system development | HIF1A ACD SPP2 WNT5A WDR19 JAG2 HOXA11 HOXC4 HOXC8 HOXD11 ACAN LRP6 | 1.67e-04 | 615 | 115 | 12 | GO:0001501 |
| GeneOntologyBiologicalProcess | dopaminergic neuron differentiation | 1.73e-04 | 50 | 115 | 4 | GO:0071542 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | FLNA HIF1A WNT5A ETV4 SEMA5A RYR2 JAG2 HOXA11 HOXD11 BTBD7 FZD5 LRP6 | 1.77e-04 | 619 | 115 | 12 | GO:0002009 |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | MAGEA3 PRAMEF7 FLNA HIF1A PRAMEF9 PIM2 RASA1 WNT5A PRAMEF15 APC SEMA5A PRAMEF4 PRAMEF8 EGR3 TMBIM4 LRP6 PRAMEF27 | 1.78e-04 | 1133 | 115 | 17 | GO:0043066 |
| GeneOntologyBiologicalProcess | head development | FLNA HIF1A WNT5A SEMA5A CRTAC1 RTN1 CD3E CELSR2 PITX3 SEC16A SLITRK5 LRP6 HSD3B2 VPS13B EPHB1 | 1.80e-04 | 919 | 115 | 15 | GO:0060322 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway involved in heart development | 1.84e-04 | 4 | 115 | 2 | GO:0003306 | |
| GeneOntologyBiologicalProcess | polysaccharide digestion | 1.84e-04 | 4 | 115 | 2 | GO:0044245 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PRAMEF7 FLNA FLNC HIF1A PSG3 WNT5A PRAMEF15 SEMA5A PRAMEF4 PRAMEF8 CRHR2 HOXA11 PTPRB HOXD11 EGR3 FZD5 LPA LRP6 VPS13B EPHB1 | 1.91e-04 | 1483 | 115 | 20 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | FLNA ICOSLG RASA1 PSG3 WNT5A APC SEMA5A CR1 JAG2 CD3E RND1 CELSR2 EGR3 VNN1 LPA | 1.98e-04 | 927 | 115 | 15 | GO:0030155 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 2.51e-04 | 55 | 115 | 4 | GO:0060071 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | MAGEA3 PRAMEF7 FLNA HIF1A PRAMEF9 PIM2 RASA1 WNT5A PRAMEF15 APC SEMA5A PRAMEF4 PRAMEF8 EGR3 TMBIM4 LRP6 PRAMEF27 | 2.63e-04 | 1171 | 115 | 17 | GO:0043069 |
| GeneOntologyBiologicalProcess | cell migration in hindbrain | 2.76e-04 | 23 | 115 | 3 | GO:0021535 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 2.78e-04 | 226 | 115 | 7 | GO:0050680 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FLNA HIF1A WNT5A APC ETV4 SEMA5A RYR2 JAG2 HOXA11 HOXD11 BTBD7 FZD5 LRP6 | 2.82e-04 | 750 | 115 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | regulation of COPII vesicle coating | 3.05e-04 | 5 | 115 | 2 | GO:0003400 | |
| GeneOntologyBiologicalProcess | formation of radial glial scaffolds | 3.05e-04 | 5 | 115 | 2 | GO:0021943 | |
| GeneOntologyBiologicalProcess | neuron recognition | 3.29e-04 | 59 | 115 | 4 | GO:0008038 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 3.29e-04 | 59 | 115 | 4 | GO:0086065 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 3.34e-04 | 233 | 115 | 7 | GO:0061351 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 3.48e-04 | 108 | 115 | 5 | GO:0035019 | |
| GeneOntologyBiologicalProcess | eye development | 3.57e-04 | 480 | 115 | 10 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 3.75e-04 | 483 | 115 | 10 | GO:0150063 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 3.97e-04 | 171 | 115 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.99e-04 | 62 | 115 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | sensory system development | 4.27e-04 | 491 | 115 | 10 | GO:0048880 | |
| GeneOntologyBiologicalProcess | axis specification | 4.29e-04 | 113 | 115 | 5 | GO:0009798 | |
| GeneOntologyBiologicalProcess | cartilage development | 4.30e-04 | 243 | 115 | 7 | GO:0051216 | |
| GeneOntologyBiologicalProcess | neuron development | FLNA KREMEN1 WNT5A APC ETV4 SEMA5A CRTAC1 CSMD3 CD3E RND1 CELSR2 PTPRK SEMA5B PITX3 SLITRK5 LRP6 PALLD VPS13B EPHB1 | 4.53e-04 | 1463 | 115 | 19 | GO:0048666 |
| GeneOntologyBiologicalProcess | intestinal epithelial cell maturation | 4.56e-04 | 6 | 115 | 2 | GO:0060574 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 5.00e-04 | 28 | 115 | 3 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 5.00e-04 | 28 | 115 | 3 | GO:0007413 | |
| GeneOntologyBiologicalProcess | blastocyst development | 5.06e-04 | 179 | 115 | 6 | GO:0001824 | |
| GeneOntologyBiologicalProcess | telencephalon development | 5.51e-04 | 332 | 115 | 8 | GO:0021537 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | HIF1A PSG3 WNT5A APC ETV4 SEMA5A EXTL3 PTPRK EGR3 LRP6 ATP5F1A | 5.55e-04 | 603 | 115 | 11 | GO:0050673 |
| GeneOntologyBiologicalProcess | branching involved in mammary gland duct morphogenesis | 6.14e-04 | 30 | 115 | 3 | GO:0060444 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | HIF1A ACD WNT5A RYR2 WDR19 JAG2 HOXA11 TBC1D32 HOXC4 HOXD11 FZD5 LRP6 | 6.33e-04 | 713 | 115 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF, modulating synaptic transmission | 6.35e-04 | 7 | 115 | 2 | GO:0099183 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 6.35e-04 | 7 | 115 | 2 | GO:0060831 | |
| GeneOntologyBiologicalProcess | muscle cell cellular homeostasis | 6.77e-04 | 31 | 115 | 3 | GO:0046716 | |
| GeneOntologyBiologicalProcess | connective tissue development | 6.82e-04 | 343 | 115 | 8 | GO:0061448 | |
| GeneOntologyBiologicalProcess | regulation of non-canonical Wnt signaling pathway | 7.44e-04 | 32 | 115 | 3 | GO:2000050 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 7.44e-04 | 32 | 115 | 3 | GO:0048596 | |
| GeneOntologyBiologicalProcess | regulation of animal organ formation | 7.44e-04 | 32 | 115 | 3 | GO:0003156 | |
| GeneOntologyBiologicalProcess | neuron projection development | FLNA KREMEN1 WNT5A APC ETV4 SEMA5A CRTAC1 CSMD3 CD3E CELSR2 PTPRK SEMA5B SLITRK5 LRP6 PALLD VPS13B EPHB1 | 7.59e-04 | 1285 | 115 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | gamma-delta T cell activation | 8.15e-04 | 33 | 115 | 3 | GO:0046629 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF | 8.44e-04 | 8 | 115 | 2 | GO:0099191 | |
| GeneOntologyBiologicalProcess | cell proliferation in midbrain | 8.44e-04 | 8 | 115 | 2 | GO:0033278 | |
| GeneOntologyBiologicalProcess | regulation of chaperone-mediated autophagy | 8.44e-04 | 8 | 115 | 2 | GO:1904714 | |
| GeneOntologyBiologicalProcess | regulation of chondrocyte development | 8.44e-04 | 8 | 115 | 2 | GO:0061181 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 8.44e-04 | 8 | 115 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 8.58e-04 | 198 | 115 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | axon development | FLNA KREMEN1 WNT5A APC ETV4 SEMA5A CRTAC1 SEMA5B SLITRK5 PALLD EPHB1 | 9.28e-04 | 642 | 115 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 9.32e-04 | 277 | 115 | 7 | GO:0048705 | |
| GeneOntologyBiologicalProcess | blastocyst formation | 9.52e-04 | 78 | 115 | 4 | GO:0001825 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 9.62e-04 | 135 | 115 | 5 | GO:2000177 | |
| GeneOntologyBiologicalProcess | central nervous system development | FLNA HIF1A WNT5A SEMA5A CRTAC1 RTN1 CD3E CELSR2 ACAN PITX3 SEC16A SLITRK5 LRP6 HSD3B2 VPS13B EPHB1 | 9.85e-04 | 1197 | 115 | 16 | GO:0007417 |
| GeneOntologyBiologicalProcess | urogenital system development | 9.99e-04 | 79 | 115 | 4 | GO:0001655 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.00e-03 | 204 | 115 | 6 | GO:0048592 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 1.05e-03 | 80 | 115 | 4 | GO:2000179 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 1.05e-03 | 80 | 115 | 4 | GO:0003143 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.56e-07 | 47 | 125 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | receptor complex | GABRG1 FLNA PSG3 CUBN TLR6 CR1 CR1L PLA2R1 CD3E PTPRB KCTD16 SLITRK5 ABCG8 | 4.60e-05 | 581 | 125 | 13 | GO:0043235 |
| MousePheno | detached sperm flagellum | 1.10e-05 | 21 | 95 | 4 | MP:0008893 | |
| MousePheno | abnormal spermatogonia proliferation | 1.60e-05 | 47 | 95 | 5 | MP:0002685 | |
| MousePheno | abnormal intersomitic vessel morphology | 4.17e-05 | 29 | 95 | 4 | MP:0012253 | |
| MousePheno | cleft upper lip | 4.79e-05 | 30 | 95 | 4 | MP:0005170 | |
| MousePheno | abnormal lip shape | 4.79e-05 | 30 | 95 | 4 | MP:0003771 | |
| MousePheno | abnormal autopod morphology | ACD WNT5A HUNK WDR19 JAG2 HOXA11 TBC1D32 HOXC8 HOXD11 ACAN LRP6 | 6.61e-05 | 390 | 95 | 11 | MP:0000572 |
| MousePheno | abnormal digit morphology | 6.70e-05 | 323 | 95 | 10 | MP:0002110 | |
| MousePheno | abnormal duodenum morphology | 7.24e-05 | 64 | 95 | 5 | MP:0003271 | |
| MousePheno | abnormal sperm number | PRAMEF7 LRAT SPATA6 SLC26A4 PRAMEF15 PRAMEF4 PRAMEF8 RIMBP3 HOXA11 RIMBP3C RIMBP3B PRAMEF27 VPS13B ADAMTSL2 | 7.77e-05 | 624 | 95 | 14 | MP:0002673 |
| MousePheno | abnormal tail morphology | PRAMEF7 ACD WNT5A PRAMEF15 PRAMEF4 PRAMEF8 JAG2 ACAN LRP6 MMP11 ADAMTSL2 | 8.86e-05 | 403 | 95 | 11 | MP:0002111 |
| MousePheno | abnormal large intestine morphology | 1.07e-04 | 276 | 95 | 9 | MP:0000489 | |
| MousePheno | abnormal upper lip morphology | 1.11e-04 | 37 | 95 | 4 | MP:0012523 | |
| MousePheno | sacral vertebral transformation | 1.60e-04 | 16 | 95 | 3 | MP:0004617 | |
| MousePheno | abnormal jejunum morphology | 1.67e-04 | 41 | 95 | 4 | MP:0004002 | |
| MousePheno | decreased germ cell number | PRAMEF7 LRAT SPATA6 WNT5A SLC26A4 PRAMEF15 PRAMEF4 PRAMEF8 RIMBP3 HOXA11 RIMBP3C RIMBP3B PRAMEF27 VPS13B | 2.13e-04 | 687 | 95 | 14 | MP:0002209 |
| MousePheno | abnormal lip morphology | 2.41e-04 | 45 | 95 | 4 | MP:0003769 | |
| MousePheno | abnormal lens morphology | PRAMEF7 PRAMEF15 PRAMEF4 CUBN PRAMEF8 TBC1D32 CRYGC PTPRK ZNRF3 FZD5 PITX3 PRAMEF27 ABCG8 VPS13B | 2.55e-04 | 699 | 95 | 14 | MP:0001303 |
| MousePheno | increased lumbar vertebrae number | 2.72e-04 | 4 | 95 | 2 | MP:0004650 | |
| MousePheno | ectopic manchette | 2.72e-04 | 19 | 95 | 3 | MP:0009377 | |
| MousePheno | abnormal urinary bladder morphology | PRAMEF7 CACNA2D1 WNT5A PRAMEF15 PRAMEF4 PRAMEF8 SLITRK5 EPHB1 | 2.74e-04 | 247 | 95 | 8 | MP:0000538 |
| MousePheno | increased male germ cell apoptosis | 3.00e-04 | 189 | 95 | 7 | MP:0014052 | |
| MousePheno | decreased male germ cell number | PRAMEF7 LRAT SPATA6 SLC26A4 PRAMEF15 PRAMEF4 PRAMEF8 RIMBP3 HOXA11 RIMBP3C RIMBP3B PRAMEF27 VPS13B | 3.77e-04 | 640 | 95 | 13 | MP:0004901 |
| MousePheno | abnormal germ cell physiology | PRAMEF7 WNT5A PRAMEF15 PRAMEF4 PRAMEF8 HOXA11 PRAMEF27 VPS13B | 4.62e-04 | 267 | 95 | 8 | MP:0020363 |
| Domain | PRAME_family | 9.60e-08 | 19 | 117 | 5 | IPR026271 | |
| Domain | DUF1220 | 4.67e-07 | 11 | 117 | 4 | PF06758 | |
| Domain | NBPF_dom | 4.67e-07 | 11 | 117 | 4 | IPR010630 | |
| Domain | NBPF | 4.67e-07 | 11 | 117 | 4 | PS51316 | |
| Domain | MAGE_N | 6.56e-06 | 20 | 117 | 4 | SM01392 | |
| Domain | MAGE_N | 9.81e-06 | 22 | 117 | 4 | PF12440 | |
| Domain | MAGE_N | 9.81e-06 | 22 | 117 | 4 | IPR021072 | |
| Domain | DUF1220 | 1.96e-05 | 9 | 117 | 3 | SM01148 | |
| Domain | MAGEA3/MAGEA6 | 3.89e-05 | 2 | 117 | 2 | IPR030097 | |
| Domain | MAGE | 5.87e-05 | 34 | 117 | 4 | SM01373 | |
| Domain | MAGE | 7.38e-05 | 36 | 117 | 4 | PS50838 | |
| Domain | MHD_dom | 7.38e-05 | 36 | 117 | 4 | IPR002190 | |
| Domain | MAGE | 7.38e-05 | 36 | 117 | 4 | PF01454 | |
| Domain | DUF3528 | 1.16e-04 | 3 | 117 | 2 | IPR021918 | |
| Domain | DUF3528 | 1.16e-04 | 3 | 117 | 2 | PF12045 | |
| Domain | CUB | 2.49e-04 | 49 | 117 | 4 | PF00431 | |
| Domain | CUB | 2.70e-04 | 50 | 117 | 4 | SM00042 | |
| Domain | - | 3.14e-04 | 52 | 117 | 4 | 2.60.120.290 | |
| Domain | Sushi | 3.14e-04 | 52 | 117 | 4 | PF00084 | |
| Domain | CUB | 3.38e-04 | 53 | 117 | 4 | PS01180 | |
| Domain | FN3_dom | 3.48e-04 | 209 | 117 | 7 | IPR003961 | |
| Domain | CCP | 3.63e-04 | 54 | 117 | 4 | SM00032 | |
| Domain | SUSHI | 4.18e-04 | 56 | 117 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 4.47e-04 | 57 | 117 | 4 | IPR000436 | |
| Domain | CUB_dom | 4.47e-04 | 57 | 117 | 4 | IPR000859 | |
| Domain | Kringle-like | 1.04e-03 | 32 | 117 | 3 | IPR013806 | |
| Domain | FN3 | 1.10e-03 | 185 | 117 | 6 | SM00060 | |
| Domain | Homeobox_CS | 1.13e-03 | 186 | 117 | 6 | IPR017970 | |
| Domain | Ig-like_fold | FLNA ICOSLG FLNC PSG3 RIMBP3 CD3E PTPRB PTPRK RIMBP3C RIMBP3B PALLD EPHB1 | 1.58e-03 | 706 | 117 | 12 | IPR013783 |
| Domain | FN3 | 1.59e-03 | 199 | 117 | 6 | PS50853 | |
| Domain | IG_FLMN | 1.69e-03 | 10 | 117 | 2 | SM00557 | |
| Domain | Filamin | 2.06e-03 | 11 | 117 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.06e-03 | 11 | 117 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.06e-03 | 11 | 117 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.06e-03 | 11 | 117 | 2 | IPR017868 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 1.78e-05 | 28 | 80 | 4 | M77 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 3.92e-05 | 34 | 80 | 4 | M27405 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 7.62e-05 | 15 | 80 | 3 | M27273 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.20e-04 | 45 | 80 | 4 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 1.31e-04 | 46 | 80 | 4 | M47409 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 1.35e-04 | 18 | 80 | 3 | M31 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.48e-04 | 89 | 80 | 5 | M39563 | |
| Pathway | WNT_SIGNALING | 1.48e-04 | 89 | 80 | 5 | M5493 | |
| Pathway | PID_WNT_CANONICAL_PATHWAY | 1.87e-04 | 20 | 80 | 3 | M90 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 1.87e-04 | 20 | 80 | 3 | MM15155 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 2.17e-04 | 21 | 80 | 3 | M27401 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 2.33e-04 | 98 | 80 | 5 | M39731 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.73e-04 | 158 | 80 | 6 | MM14791 | |
| Pathway | REACTOME_DIGESTION | 2.87e-04 | 23 | 80 | 3 | M27790 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 4.09e-04 | 239 | 80 | 7 | MM14756 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 4.51e-04 | 113 | 80 | 5 | M39669 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 5.20e-04 | 28 | 80 | 3 | M27837 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 7.05e-04 | 31 | 80 | 3 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 7.05e-04 | 31 | 80 | 3 | MM15154 | |
| Pathway | WP_AXON_GUIDANCE | 7.38e-04 | 72 | 80 | 4 | M48335 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 7.75e-04 | 32 | 80 | 3 | M23 | |
| Pathway | KEGG_AXON_GUIDANCE | 8.25e-04 | 129 | 80 | 5 | M5539 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 8.71e-04 | 8 | 80 | 2 | MM14717 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 8.71e-04 | 8 | 80 | 2 | M27433 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 8.71e-04 | 8 | 80 | 2 | MM14976 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.10e-03 | 36 | 80 | 3 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.19e-03 | 37 | 80 | 3 | M47411 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.39e-03 | 39 | 80 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.39e-03 | 39 | 80 | 3 | MM15165 | |
| Pubmed | 4.34e-15 | 21 | 125 | 8 | 16079250 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.37e-10 | 10 | 125 | 5 | 22973535 | |
| Pubmed | The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. | 1.08e-09 | 14 | 125 | 5 | 8575766 | |
| Pubmed | Structure, chromosomal localization, and expression of 12 genes of the MAGE family. | 1.61e-09 | 15 | 125 | 5 | 7927540 | |
| Pubmed | 2.85e-09 | 35 | 125 | 6 | 19389355 | ||
| Pubmed | Expression of melanoma-associated antigens in oral squamous cell carcinoma. | 5.52e-09 | 7 | 125 | 4 | 18197853 | |
| Pubmed | 8.22e-09 | 20 | 125 | 5 | 26694250 | ||
| Pubmed | MAGE cancer-testis antigens protect the mammalian germline under environmental stress. | 1.10e-08 | 8 | 125 | 4 | 31149633 | |
| Pubmed | The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice. | 1.10e-08 | 8 | 125 | 4 | 27226137 | |
| Pubmed | 1.39e-08 | 22 | 125 | 5 | 31729367 | ||
| Pubmed | 2.77e-08 | 25 | 125 | 5 | 37451217 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 20660348 | ||
| Pubmed | 5.09e-08 | 28 | 125 | 5 | 25089626 | ||
| Pubmed | Membrane protein Crry maintains homeostasis of the complement system. | 1.81e-07 | 4 | 125 | 3 | 18684964 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.81e-07 | 4 | 125 | 3 | 19091768 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 3.65e-07 | 17 | 125 | 4 | 23565261 | |
| Pubmed | 3.65e-07 | 17 | 125 | 4 | 37781892 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 20675597 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 8037761 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 17916747 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 17015743 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 4.51e-07 | 5 | 125 | 3 | 17855024 | |
| Pubmed | 4.68e-07 | 18 | 125 | 4 | 23894331 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 4.68e-07 | 18 | 125 | 4 | 39181896 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 4.68e-07 | 18 | 125 | 4 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 4.68e-07 | 18 | 125 | 4 | 29731491 | |
| Pubmed | 4.68e-07 | 18 | 125 | 4 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 5.91e-07 | 19 | 125 | 4 | 28604677 | |
| Pubmed | 7.37e-07 | 20 | 125 | 4 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 7.37e-07 | 20 | 125 | 4 | 21425410 | |
| Pubmed | PRAMEF7 MAGEA11 SPP2 PSG3 ZNF280C PRAMEF15 PRAMEF4 PRAMEF8 PLA2R1 HOXC8 RND1 KLHDC7A SPIC | 1.02e-06 | 674 | 125 | 13 | 37196079 | |
| Pubmed | 1.34e-06 | 23 | 125 | 4 | 19480014 | ||
| Pubmed | 1.35e-06 | 383 | 125 | 10 | 19453261 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 22134685 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 17634428 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 1.90e-06 | 25 | 125 | 4 | 12620990 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 2.24e-06 | 26 | 125 | 4 | 18500982 | |
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 14670299 | ||
| Pubmed | 3.52e-06 | 29 | 125 | 4 | 2574852 | ||
| Pubmed | 3.56e-06 | 64 | 125 | 5 | 24431302 | ||
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 4.05e-06 | 30 | 125 | 4 | 38786026 | |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 5.29e-06 | 32 | 125 | 4 | 37889087 | |
| Pubmed | 6.00e-06 | 33 | 125 | 4 | 31143371 | ||
| Pubmed | 6.78e-06 | 34 | 125 | 4 | 23293290 | ||
| Pubmed | 7.32e-06 | 11 | 125 | 3 | 18606138 | ||
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 7.32e-06 | 11 | 125 | 3 | 23204401 | |
| Pubmed | ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. | 7.32e-06 | 11 | 125 | 3 | 22575959 | |
| Pubmed | 9.58e-06 | 37 | 125 | 4 | 15342465 | ||
| Pubmed | 9.74e-06 | 12 | 125 | 3 | 18524992 | ||
| Pubmed | 1.07e-05 | 38 | 125 | 4 | 11857506 | ||
| Pubmed | 1.07e-05 | 38 | 125 | 4 | 15042701 | ||
| Pubmed | 1.19e-05 | 39 | 125 | 4 | 33257809 | ||
| Pubmed | Functional identification of transcription control sequences of the mouse Crry gene. | 1.28e-05 | 2 | 125 | 2 | 8335915 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 8104467 | ||
| Pubmed | Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. | 1.28e-05 | 2 | 125 | 2 | 10779754 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16444293 | ||
| Pubmed | Antibody targeting of E3 ubiquitin ligases for receptor degradation. | 1.28e-05 | 2 | 125 | 2 | 36131013 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 30056111 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 35605119 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 1730912 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25240054 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23764752 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19740350 | ||
| Pubmed | Functional equivalence and rescue among group 11 Hox gene products in vertebral patterning. | 1.28e-05 | 2 | 125 | 2 | 8660870 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18174455 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34359960 | ||
| Pubmed | A regulatory feedback loop between HIF-1α and PIM2 in HepG2 cells. | 1.28e-05 | 2 | 125 | 2 | 24505470 | |
| Pubmed | A member of the Frizzled protein family mediating axis induction by Wnt-5A. | 1.28e-05 | 2 | 125 | 2 | 9054360 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19177143 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 7689010 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 2952719 | ||
| Pubmed | Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11. | 1.28e-05 | 2 | 125 | 2 | 7596412 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 10679933 | ||
| Pubmed | The Wingless homolog Wnt5a stimulates phagocytosis but not bacterial killing. | 1.28e-05 | 2 | 125 | 2 | 23012420 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31934854 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12767833 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 35022469 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 1.28e-05 | 2 | 125 | 2 | 24469451 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20484840 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17674370 | ||
| Pubmed | Activation of HIF-1α does not increase intestinal tumorigenesis. | 1.28e-05 | 2 | 125 | 2 | 24875099 | |
| Pubmed | Functional interaction between co-expressed MAGE-A proteins. | 1.28e-05 | 2 | 125 | 2 | 28542476 | |
| Pubmed | Absence of mutations in the HOXA11 and HOXD11 genes in children with congenital renal malformations. | 1.28e-05 | 2 | 125 | 2 | 19255789 | |
| Pubmed | Comprehensive microarray analysis of Hoxa11/Hoxd11 mutant kidney development. | 1.28e-05 | 2 | 125 | 2 | 16581055 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11698469 | ||
| Pubmed | Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones. | 1.28e-05 | 2 | 125 | 2 | 34709768 | |
| Pubmed | The murine complement regulator Crry: new insights into the immunobiology of complement regulation. | 1.28e-05 | 2 | 125 | 2 | 11915940 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 7691944 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 2911011 | ||
| Pubmed | Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection. | 1.28e-05 | 2 | 125 | 2 | 20844082 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22707303 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12902517 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17015675 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23153828 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17387143 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12973023 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 10586048 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16301687 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 36450590 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25564441 | ||
| Cytoband | 1p36.21 | 8.55e-07 | 63 | 125 | 5 | 1p36.21 | |
| Cytoband | Xq28 | 9.37e-06 | 176 | 125 | 6 | Xq28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.61e-05 | 404 | 125 | 8 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq28 | 2.75e-05 | 213 | 125 | 6 | chrXq28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF7 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF8 NBPF1 KLHDC7A PRAMEF27 | 5.79e-04 | 681 | 125 | 8 | chr1p36 |
| Cytoband | 1q21.1 | 6.63e-04 | 62 | 125 | 3 | 1q21.1 | |
| Cytoband | 2q33.3 | 3.04e-03 | 30 | 125 | 2 | 2q33.3 | |
| Cytoband | 22q12.1 | 3.46e-03 | 32 | 125 | 2 | 22q12.1 | |
| Cytoband | 22q11.21 | 3.53e-03 | 111 | 125 | 3 | 22q11.21 | |
| Cytoband | 4q32.3 | 3.90e-03 | 34 | 125 | 2 | 4q32.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q32 | 4.39e-03 | 120 | 125 | 3 | chr4q32 | |
| Cytoband | 4p14 | 5.90e-03 | 42 | 125 | 2 | 4p14 | |
| GeneFamily | Neuroblastoma breakpoint family | 1.52e-13 | 23 | 92 | 8 | 662 | |
| GeneFamily | PRAME family | 1.84e-09 | 24 | 92 | 6 | 686 | |
| GeneFamily | MAGE family | 1.75e-06 | 40 | 92 | 5 | 1136 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.04e-05 | 57 | 92 | 5 | 1179 | |
| GeneFamily | HOXL subclass homeoboxes | 1.41e-04 | 52 | 92 | 4 | 518 | |
| GeneFamily | Complement system|Sushi domain containing | 8.06e-04 | 36 | 92 | 3 | 492 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 4.58e-03 | 20 | 92 | 2 | 736 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.05e-03 | 21 | 92 | 2 | 813 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | MAGEA3 MAGEA6 PRAMEF7 MAGEA11 MAGEA12 SLC26A4 PRAMEF15 PRAMEF4 PRAMEF8 SPIC | 2.81e-06 | 317 | 124 | 10 | MM956 |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 7.32e-06 | 98 | 124 | 6 | MM592 | |
| Coexpression | BENPORATH_PRC2_TARGETS | SLC26A4 CRTAC1 CSMD3 IRX4 RIMBP3 HOXC4 HOXC8 EGR3 PITX3 RIMBP3C CACNA1G RIMBP3B EPHB1 | 1.31e-05 | 650 | 124 | 13 | M8448 |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 1.98e-05 | 34 | 124 | 4 | MM955 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | SLC26A4 CRTAC1 CSMD3 IRX4 RIMBP3 HOXC4 HOXC8 HOXD11 EGR3 ACAN PITX3 SLITRK5 RIMBP3C CACNA1G RIMBP3B EPHB1 | 3.10e-05 | 1035 | 124 | 16 | M9898 |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 4.20e-05 | 81 | 124 | 5 | MM938 | |
| Coexpression | YEGNASUBRAMANIAN_PROSTATE_CANCER | 4.53e-05 | 135 | 124 | 6 | M4034 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | PRAMEF7 SPATA6 PIM2 PSG3 PRAMEF15 PRAMEF4 EXTL3 PRAMEF8 CD3E SPIC | 7.29e-05 | 463 | 124 | 10 | MM1011 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | LRAT SLC26A4 CRTAC1 CSMD3 IRX4 RIMBP3 HOXC4 HOXC8 EGR3 ACAN PITX3 RIMBP3C CACNA1G GNAO1 RIMBP3B EPHB1 | 7.50e-05 | 1115 | 124 | 16 | M10371 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 2.35e-05 | 62 | 117 | 5 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 3.79e-05 | 166 | 117 | 7 | gudmap_kidney_P3_CapMes_Crym_200 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-08 | 195 | 125 | 8 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-07 | 186 | 125 | 7 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-07 | 186 | 125 | 7 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.74e-07 | 186 | 125 | 7 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.08e-06 | 155 | 125 | 6 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-06 | 157 | 125 | 6 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.67e-06 | 158 | 125 | 6 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.52e-06 | 166 | 125 | 6 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.52e-06 | 173 | 125 | 6 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | PBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 1.12e-05 | 178 | 125 | 6 | 0667abc05eb2254710b9c648c65b7cfdfe7831b7 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 180 | 125 | 6 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 185 | 125 | 6 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 186 | 125 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 187 | 125 | 6 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 187 | 125 | 6 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 187 | 125 | 6 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-05 | 190 | 125 | 6 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 191 | 125 | 6 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 191 | 125 | 6 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 191 | 125 | 6 | d4f535b06ad483448ab692e9900c872c78cbed60 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 191 | 125 | 6 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 191 | 125 | 6 | b5210de890d338602857b5907135705a507bc2b0 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 195 | 125 | 6 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.93e-05 | 196 | 125 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.93e-05 | 196 | 125 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.93e-05 | 196 | 125 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.04e-05 | 198 | 125 | 6 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-05 | 198 | 125 | 6 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | droplet-Skin-nan-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 122 | 125 | 5 | 8f675dc341b3f6e22f7e52c34d167d9e37df0982 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 122 | 125 | 5 | c7e81504e62d132624ec15b7d38dc5b6493a37a4 | |
| ToppCell | droplet-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 125 | 125 | 5 | 5a309ce803d2b8efd791eb21808121bf5fc3ea8e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 137 | 125 | 5 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 137 | 125 | 5 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.97e-05 | 152 | 125 | 5 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.19e-05 | 153 | 125 | 5 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.65e-05 | 155 | 125 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 8.13e-05 | 157 | 125 | 5 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | Healthy/Control-RBC|Healthy/Control / Disease group and Cell class | 8.37e-05 | 158 | 125 | 5 | 1fec4f9affdbfba2e281183b717d4d357d474400 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.88e-05 | 160 | 125 | 5 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.88e-05 | 160 | 125 | 5 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 9.15e-05 | 161 | 125 | 5 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 9.70e-05 | 163 | 125 | 5 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-04 | 165 | 125 | 5 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 166 | 125 | 5 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 166 | 125 | 5 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 166 | 125 | 5 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 166 | 125 | 5 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.09e-04 | 167 | 125 | 5 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 167 | 125 | 5 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.09e-04 | 167 | 125 | 5 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 168 | 125 | 5 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.18e-04 | 170 | 125 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 173 | 125 | 5 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 173 | 125 | 5 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 174 | 125 | 5 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 174 | 125 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 174 | 125 | 5 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.35e-04 | 175 | 125 | 5 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.37e-04 | 93 | 125 | 4 | 3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-04 | 176 | 125 | 5 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 176 | 125 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 177 | 125 | 5 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 180 | 125 | 5 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 180 | 125 | 5 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 180 | 125 | 5 | d685fa2b013bc085dbef7c40956ed3043f83e483 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 180 | 125 | 5 | 6327c938a4f99df9fee714e44f15ea4a4a63ae15 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 180 | 125 | 5 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 180 | 125 | 5 | b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-04 | 180 | 125 | 5 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-04 | 181 | 125 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 181 | 125 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 182 | 125 | 5 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 182 | 125 | 5 | f5f42e23832d0210560009ce6fd8eee89751e252 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-04 | 183 | 125 | 5 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 184 | 125 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.71e-04 | 184 | 125 | 5 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 184 | 125 | 5 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-04 | 184 | 125 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-04 | 184 | 125 | 5 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 184 | 125 | 5 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-04 | 185 | 125 | 5 | 42690b95e2e7d56c822211bb1150acb787cfe2e8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 186 | 125 | 5 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.84e-04 | 187 | 125 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.84e-04 | 187 | 125 | 5 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.84e-04 | 187 | 125 | 5 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-04 | 188 | 125 | 5 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.89e-04 | 188 | 125 | 5 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.89e-04 | 188 | 125 | 5 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 188 | 125 | 5 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 188 | 125 | 5 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.89e-04 | 188 | 125 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 188 | 125 | 5 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 3371_UP | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 3388_UP | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 5059_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 3748_UP | |
| Drug | furosemide | 1.43e-05 | 272 | 120 | 9 | CID000003440 | |
| Drug | Pesticides | 1.50e-05 | 150 | 120 | 7 | ctd:D010575 | |
| Disease | response to acetylsalicylate | 2.24e-05 | 16 | 103 | 3 | GO_1903492 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.63e-05 | 49 | 103 | 4 | EFO_0022256 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | CATARACT, AUTOSOMAL DOMINANT | 7.21e-05 | 4 | 103 | 2 | C1858679 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.28e-04 | 34 | 103 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 2.49e-04 | 35 | 103 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | blood sedimentation | 2.51e-04 | 7 | 103 | 2 | EFO_0004304 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.91e-04 | 257 | 103 | 6 | DOID:10652 (is_marker_for) | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 2.94e-04 | 37 | 103 | 3 | EFO_0022281 | |
| Disease | Pancreatic Neoplasm | 4.25e-04 | 100 | 103 | 4 | C0030297 | |
| Disease | aortic stenosis, aortic valve calcification | 4.30e-04 | 42 | 103 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | Malignant neoplasm of pancreas | 4.58e-04 | 102 | 103 | 4 | C0346647 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 4.61e-04 | 43 | 103 | 3 | EFO_0022290 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 5.27e-04 | 45 | 103 | 3 | EFO_0022236 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.62e-04 | 46 | 103 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | Celiac Disease | 5.99e-04 | 47 | 103 | 3 | C0007570 | |
| Disease | coronary artery disease, factor VII measurement | 6.30e-04 | 111 | 103 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | total lipids in lipoprotein particles measurement | 6.37e-04 | 48 | 103 | 3 | EFO_0022309 | |
| Disease | vascular dementia (is_marker_for) | 6.50e-04 | 11 | 103 | 2 | DOID:8725 (is_marker_for) | |
| Disease | factor VIII measurement, coronary artery disease | 6.73e-04 | 113 | 103 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | cholesterol in small LDL measurement | 6.77e-04 | 49 | 103 | 3 | EFO_0022227 | |
| Disease | metabolic syndrome | 6.96e-04 | 200 | 103 | 5 | EFO_0000195 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 7.19e-04 | 50 | 103 | 3 | EFO_0022334 | |
| Disease | factor XI measurement, coronary artery disease | 7.19e-04 | 115 | 103 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | triglycerides to total lipids in large LDL percentage | 7.62e-04 | 51 | 103 | 3 | EFO_0022331 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 7.62e-04 | 51 | 103 | 3 | EFO_0022242 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 7.92e-04 | 118 | 103 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | phospholipids in medium VLDL measurement | 8.06e-04 | 52 | 103 | 3 | EFO_0022154 | |
| Disease | generalised epilepsy | 8.06e-04 | 52 | 103 | 3 | EFO_0005917 | |
| Disease | phospholipids in large LDL measurement | 8.52e-04 | 53 | 103 | 3 | EFO_0022174 | |
| Disease | total phospholipids in lipoprotein particles measurement | 8.52e-04 | 53 | 103 | 3 | EFO_0022315 | |
| Disease | total lipids in medium VLDL | 9.00e-04 | 54 | 103 | 3 | EFO_0022153 | |
| Disease | peripheral arterial disease | 9.00e-04 | 54 | 103 | 3 | EFO_0004265 | |
| Disease | Antithrombotic agent use measurement | 9.50e-04 | 55 | 103 | 3 | EFO_0009925 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 9.62e-04 | 215 | 103 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.00e-03 | 56 | 103 | 3 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 1.00e-03 | 56 | 103 | 3 | EFO_0022279 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.05e-03 | 57 | 103 | 3 | EFO_0022284 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.07e-03 | 220 | 103 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | CD209 antigen measurement | 1.07e-03 | 14 | 103 | 2 | EFO_0008077 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.11e-03 | 58 | 103 | 3 | EFO_0022338 | |
| Disease | phospholipids in LDL measurement | 1.11e-03 | 58 | 103 | 3 | EFO_0022294 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.15e-03 | 224 | 103 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | phospholipids in VLDL measurement | 1.17e-03 | 59 | 103 | 3 | EFO_0022301 | |
| Disease | phospholipids in small LDL measurement | 1.17e-03 | 59 | 103 | 3 | EFO_0022297 | |
| Disease | polyunsaturated fatty acid measurement | 1.17e-03 | 131 | 103 | 4 | EFO_0010733 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.18e-03 | 225 | 103 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.23e-03 | 15 | 103 | 2 | EFO_0007804, GO_0036273 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.27e-03 | 229 | 103 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | free cholesterol in IDL measurement | 1.28e-03 | 61 | 103 | 3 | EFO_0022181 | |
| Disease | free cholesterol in VLDL measurement | 1.28e-03 | 61 | 103 | 3 | EFO_0022276 | |
| Disease | Malignant neoplasm of breast | FLNA HIF1A PCDHGB6 ETV4 PANX2 CUBN JAG2 HOXD11 SEMA5B KLHDC7A VPS13B | 1.33e-03 | 1074 | 103 | 11 | C0006142 |
| Disease | free cholesterol in very large HDL measurement | 1.35e-03 | 62 | 103 | 3 | EFO_0022273 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.40e-03 | 16 | 103 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.40e-03 | 16 | 103 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.40e-03 | 16 | 103 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.40e-03 | 16 | 103 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.40e-03 | 16 | 103 | 2 | C0025237 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.41e-03 | 63 | 103 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | triglycerides to total lipids in IDL percentage | 1.41e-03 | 63 | 103 | 3 | EFO_0022329 | |
| Disease | Prostatic Neoplasms | 1.44e-03 | 616 | 103 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.44e-03 | 616 | 103 | 8 | C0376358 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.54e-03 | 239 | 103 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | Van Buchem disease | 1.59e-03 | 17 | 103 | 2 | C0432272 | |
| Disease | Limb Deformities, Congenital | 1.59e-03 | 17 | 103 | 2 | C0206762 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.59e-03 | 17 | 103 | 2 | EFO_0022232 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.61e-03 | 66 | 103 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.65e-03 | 144 | 103 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 1.68e-03 | 67 | 103 | 3 | EFO_0022245 | |
| Disease | Female Urogenital Diseases | 1.78e-03 | 18 | 103 | 2 | C1720887 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.83e-03 | 69 | 103 | 3 | EFO_0022341 | |
| Disease | rheumatoid arthritis (is_marker_for) | 1.83e-03 | 69 | 103 | 3 | DOID:7148 (is_marker_for) | |
| Disease | Osteochondrodysplasias | 1.99e-03 | 19 | 103 | 2 | C0029422 | |
| Disease | cerebral infarction (is_marker_for) | 1.99e-03 | 19 | 103 | 2 | DOID:3526 (is_marker_for) | |
| Disease | Usual Interstitial Pneumonia | 1.99e-03 | 19 | 103 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 1.99e-03 | 19 | 103 | 2 | C4721508 | |
| Disease | Dyschondroplasias | 1.99e-03 | 19 | 103 | 2 | C0013366 | |
| Disease | superior temporal gyrus volume measurement | 1.99e-03 | 19 | 103 | 2 | EFO_0010331 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.99e-03 | 19 | 103 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.99e-03 | 71 | 103 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.99e-03 | 71 | 103 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | Liver carcinoma | 2.04e-03 | 507 | 103 | 7 | C2239176 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.11e-03 | 154 | 103 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | Multiple Epiphyseal Dysplasia | 2.20e-03 | 20 | 103 | 2 | C0026760 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 2.20e-03 | 20 | 103 | 2 | C4721952 | |
| Disease | very low density lipoprotein cholesterol measurement | 2.22e-03 | 260 | 103 | 5 | EFO_0008317 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 2.32e-03 | 75 | 103 | 3 | EFO_0022287 | |
| Disease | stroke, coronary artery disease | 2.43e-03 | 21 | 103 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.43e-03 | 21 | 103 | 2 | EFO_0022246 | |
| Disease | Idiopathic Pulmonary Fibrosis | 2.43e-03 | 21 | 103 | 2 | C1800706 | |
| Disease | Mammary Carcinoma, Human | 2.47e-03 | 525 | 103 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.47e-03 | 525 | 103 | 7 | C1257931 | |
| Disease | Disproportionate short stature | 2.51e-03 | 77 | 103 | 3 | C0878659 | |
| Disease | Mammary Neoplasms | 2.53e-03 | 527 | 103 | 7 | C1458155 | |
| Disease | creatinine measurement | HIF1A CUBN EEF1A2 JAG2 TBC1D10B CELSR2 HOXD11 LPA KLHDC7A MMP11 | 2.53e-03 | 995 | 103 | 10 | EFO_0004518 |
| Disease | Lung diseases | 2.60e-03 | 78 | 103 | 3 | C0024115 | |
| Disease | progranulin measurement | 2.66e-03 | 22 | 103 | 2 | EFO_0004625 | |
| Disease | Glioblastoma | 2.69e-03 | 79 | 103 | 3 | C0017636 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.79e-03 | 80 | 103 | 3 | DOID:12930 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAARPPYTLAAADYC | 341 | Q8N1M1 | |
| PSVRGQFYYISDDTP | 246 | P26439 | |
| DSYDPSTGEVYCRVP | 26 | Q9H2A2 | |
| SYICSPGYELSFPAV | 3256 | Q7Z407 | |
| ESPSECYFPSVEYTA | 981 | Q96NH3 | |
| CPRYSNPADFYVDLT | 311 | Q9H221 | |
| TSSYNCPSPYADGRL | 2641 | Q9HCU4 | |
| YPDAVYLSEGPSSCS | 191 | Q6IPU0 | |
| DAAPLQYLAPYSGCS | 281 | P25705 | |
| GEQCLYSSAYDPPRQ | 121 | P43268 | |
| CIAYSPPFGDYAQVS | 631 | Q9HCJ3 | |
| VRPSDNTPGDYSLYF | 376 | P20936 | |
| PFSYTCGDPSTYRVT | 1196 | A6NNM3 | |
| PFSYTCGDPSTYRVT | 1196 | A6NJZ7 | |
| ASAQAPVYCPVYESR | 41 | P78413 | |
| PNYSEGTLPYSYNLC | 741 | Q9Y5F9 | |
| PRGIYYPEASTCQNV | 441 | Q8NAB2 | |
| FYPYPVQTRTCRSTG | 66 | P00751 | |
| GLYPNPRERSSFYSC | 426 | Q13231 | |
| CTCRTGYYRADFDPP | 301 | P54762 | |
| GYYRADFDPPEVACT | 306 | P54762 | |
| DDPCSDYINASYIPG | 1751 | P23467 | |
| LNPDAFIAYPCRSYT | 291 | Q17RR3 | |
| PRYPRSSIEDDFNYG | 6 | Q9HC24 | |
| LEYRQVPGSDPACYE | 256 | P43356 | |
| LEYRQVPGSDPACYE | 256 | P43357 | |
| LEYRQVPGSDPACYE | 256 | P43360 | |
| YRQVPGTDPACYEFL | 371 | P43364 | |
| LEYRQVPGSDPACYE | 256 | P43365 | |
| AVYQGPESDATPCTY | 156 | Q9UKP3 | |
| NCSRYYPREQGSAVP | 6 | Q68DU8 | |
| PEPNSPSEYCFYVDS | 511 | Q16665 | |
| AEPDQYRCTCPDGYS | 326 | Q9Y219 | |
| DPTRAGICYFYPSQT | 31 | Q9NQG7 | |
| AEPSISYSCNPLYFD | 561 | Q9UKJ3 | |
| PNYSEGTLPYSYNLC | 741 | Q9Y5G2 | |
| SCAVSYLPTEPGEYT | 1116 | Q14315 | |
| LDPEGPYSYCNTTLD | 31 | Q13324 | |
| CVELYPAPRESYGAD | 411 | P0DUQ1 | |
| EENYESCPPSPYTER | 1581 | O75581 | |
| ESRPQPIYYGFSESA | 336 | Q86TH1 | |
| YSPDFPDTYATGRVC | 226 | Q96MU8 | |
| TYCRYGTPISPQSDK | 166 | O95237 | |
| PSCTYYVSGPDFSSL | 16 | P31270 | |
| YFPDCIVRPFGSSVN | 221 | Q9NVV4 | |
| PDSCLPYGSSFYALE | 1071 | Q3BBV0 | |
| GYPDPSSRYDAICYT | 336 | P16112 | |
| FTCTSINGYPRPNVY | 156 | O75144 | |
| SYLCRPDGTTTAYFP | 426 | Q8WX93 | |
| DLYPSERYPVFCSGT | 301 | O43825 | |
| ERYPVFCSGTGYVFS | 306 | O43825 | |
| PNCTLDYLAVYDGPS | 1216 | O60494 | |
| PCYQPSFSADERTFA | 221 | Q13467 | |
| PPCGLDYEAYNSSSN | 296 | O43497 | |
| FPVGTSLNYECRPGY | 1416 | P17927 | |
| PGQEVFYSCEPSYDL | 1671 | P17927 | |
| SCPLEFSSYGYPKNE | 201 | Q8N1C3 | |
| KSYDYQSVCEPGAAP | 896 | P54289 | |
| DTRTCGYPPEDHSYQ | 71 | A8K830 | |
| TCSVSYVPTEPGDYN | 1121 | P21333 | |
| CVESFSQYPPLGRFA | 411 | Q05639 | |
| PYSNCGDLYSEPVSF | 146 | Q06889 | |
| SRCPLTSGFPVYVYD | 186 | O43909 | |
| LNYECRPGYSGRPFS | 61 | Q2VPA4 | |
| GERATCCFPSYVYPD | 211 | Q9HC77 | |
| SYPERQYSCTSLQGP | 61 | P09017 | |
| YSDPFSTQCGSPAYA | 216 | P57058 | |
| LPGCAYYVAPSDFAS | 16 | P31277 | |
| DAVAAPYCYTRDPGV | 81 | P08519 | |
| AVAAPYCYTRDPGVR | 196 | P08519 | |
| RNPDAVAAPYCYTRD | 306 | P08519 | |
| DAVAAPYCYTRDPGV | 651 | P08519 | |
| AVAAPYCYTRDPGVR | 766 | P08519 | |
| YVCYPRGSKPEDANF | 96 | P07766 | |
| EYPDFYDFSNAACRP | 941 | Q9P203 | |
| GDPPCLTYLYFSAVD | 531 | Q6MZM0 | |
| GESLEPAYYDCRFPQ | 16 | P31273 | |
| PAYYDCRFPQSVGRS | 21 | P31273 | |
| LPEGSESTPQYCYDG | 691 | O75064 | |
| ESTPQYCYDGFPELR | 696 | O75064 | |
| ATYRTPYPDAFQCAV | 706 | Q5VTJ3 | |
| PRDKPVCVNTYGSYR | 571 | Q9NQ79 | |
| SYETTTDCPNLQPYF | 16 | P07315 | |
| SGCVRDDTYGPYSSP | 2321 | Q9UGM3 | |
| YPAPLESYDTQGALC | 411 | Q5VWM4 | |
| PSFVSISNECYQYSP | 1766 | Q92736 | |
| AAAAASSPYVYRDPC | 246 | O75364 | |
| YQPASPPRDACVYSS | 11 | Q96HA8 | |
| VPRYLCEGTESPYQT | 846 | Q15262 | |
| EEPIYCYTPHNFTRD | 76 | Q96RD6 | |
| YLSCFADSNPPAEYS | 351 | Q16557 | |
| FYTFRYPLSLSPDDC | 236 | P24347 | |
| YRFPELADPDTCYGF | 46 | Q9UJJ7 | |
| DICYPPQEDSTYFTG | 111 | Q16799 | |
| QPYCGIAPYIREFED | 36 | P08621 | |
| LEQPDSCQPYGSSFY | 966 | P0DPF3 | |
| LEQPDSCQPYGSSFY | 1041 | Q6P3W6 | |
| EQPDSCQPYGSSFYA | 1286 | Q6P3W6 | |
| QPDSCQPYGSSFYAL | 1531 | Q6P3W6 | |
| PDSCQPYGSSFYALE | 1776 | Q6P3W6 | |
| LEQPDSCQPYGSSFY | 2261 | Q6P3W6 | |
| EQPDSCQPYGSSFYA | 2506 | Q6P3W6 | |
| QPDSCQPYGSSFYAL | 2751 | Q6P3W6 | |
| PDSCQPYGSSFYALE | 2996 | Q6P3W6 | |
| TPSGYLELTDSCQPY | 3326 | Q6P3W6 | |
| LEQPDSCQPYGSSFY | 3481 | Q6P3W6 | |
| PDSCQPYRSSFYALE | 1071 | Q5TAG4 | |
| LEQPDSCQPYGSSFY | 776 | Q5TI25 | |
| LEQPDSCQPYGSSFY | 526 | Q8N660 | |
| LEQPDSCQPYGSSFY | 526 | A0A087WUL8 | |
| EQPDSCQPYGSSFYA | 771 | A0A087WUL8 | |
| QPDSCQPYGSSFYAL | 1016 | A0A087WUL8 | |
| PDSCQPYGSSFYALE | 1261 | A0A087WUL8 | |
| LEQPDSCQPYGSSFY | 1746 | A0A087WUL8 | |
| EQPDSCQPYGSSFYA | 1991 | A0A087WUL8 | |
| QPDSCQPYGSSFYAL | 2236 | A0A087WUL8 | |
| PDSCQPYGSSFYALE | 2481 | A0A087WUL8 | |
| LEQPDSCQPYGSSFY | 2966 | A0A087WUL8 | |
| EQPDSCQPYGSSFYA | 3211 | A0A087WUL8 | |
| QPDSCQPYGSSFYAL | 3456 | A0A087WUL8 | |
| PDSCQPYGSSFYALE | 3701 | A0A087WUL8 | |
| LEQPDSCQPYGSSFY | 426 | P0DPF2 | |
| EQPDSCQPYGSSFYA | 671 | P0DPF2 | |
| QPDSCQPYGSSFYAL | 916 | P0DPF2 | |
| PDSCQPYGSSFYALE | 1161 | P0DPF2 | |
| LEQPDSCQPYGSSFY | 1646 | P0DPF2 | |
| EQPDSCQPYGSSFYA | 1891 | P0DPF2 | |
| QPDSCQPYGSSFYAL | 2136 | P0DPF2 | |
| PDSCQPYGSSFYALE | 2381 | P0DPF2 | |
| LEQPDSCQPYGSSFY | 2866 | P0DPF2 | |
| EQPDSCQPYGSSFYA | 3111 | P0DPF2 | |
| QPDSCQPYGSSFYAL | 3356 | P0DPF2 | |
| PDSCQPYGSSFYALE | 3601 | P0DPF2 | |
| LEQPDSCQPYGSSFY | 4086 | P0DPF2 | |
| EQPDSCQPYGSSFYA | 4331 | P0DPF2 | |
| QPDSCQPYGSSFYAL | 4501 | P0DPF2 | |
| PDSCQPYGSSFYALE | 4821 | P0DPF2 | |
| PFSYTCGDPSTYRVT | 1196 | Q9UFD9 | |
| SPYYDNVRPLCYSDS | 71 | Q92730 | |
| DEPYTDFDGTRVYSP | 191 | Q9P1W9 | |
| ICFPEYTGPNTYEDA | 286 | P09471 | |
| SPCDPDRDQRYLTTY | 331 | Q7Z5V6 | |
| SCSGFPVYDYDPSSL | 26 | Q13103 | |
| CVEVYPAPRESYGAD | 411 | A3QJZ7 | |
| YCPVNDATYEIPDFS | 541 | Q8NEZ3 | |
| APECYFPRQDNSYSV | 971 | P14410 | |
| SSCYGVLPTEEPVYN | 51 | Q8N5J4 | |
| FDQASSGYYCPPALV | 536 | Q13018 | |
| LNCSRPGEVPFYYNE | 276 | Q13591 | |
| GSAFQYEYEPPCTSL | 411 | Q96AP0 | |
| YTPIEGTPYCFSRND | 1846 | P25054 | |
| AVPYSPRDENGSFVY | 351 | G9CGD6 | |
| AVPYSPRDENGSFVY | 351 | Q6P9H4 | |
| YPAPLESYDTQGALC | 411 | Q5VXH5 | |
| CVELYPAPRESYGAD | 411 | O60810 | |
| NGPTFSSTPYRYQAC | 236 | Q9HCU5 | |
| YFSPCYSIGTNNTAP | 461 | Q6AZZ1 | |
| DTSDPQCPPDGRYQY | 146 | O95497 | |
| YEYAQSLGAETCPLP | 1786 | O15027 | |
| GRSEPPQLPEYSCSY | 6 | O43511 | |
| PCSPAAYTFSPNYDL | 881 | O94991 | |
| CDSTLGPAYYKPQFD | 116 | Q8N412 | |
| CVELYPAPRESYGAD | 411 | P0DUQ2 | |
| CTFTDTFTGPLRPYF | 436 | A6NK02 | |
| TIYRPDEGYCQAQAP | 436 | Q4KMP7 | |
| YIDPSPDYCVRNEST | 301 | P41221 | |
| CSRPGEVPFYYNELQ | 346 | Q9P283 | |
| CDYPESYRGSPLKDF | 561 | Q9Y2C9 | |
| YFRVPDSATFSICPG | 3136 | Q7Z7G8 | |
| SSDYDPFIYRSRSPC | 591 | Q9ULT6 | |
| SSPYDAGADYLRACP | 226 | Q8ND82 | |
| AYDSDPEYSSCQQPR | 421 | Q9NWH7 | |
| PYPCPDCGRRFTYSS | 311 | A8K8V0 |